327 related articles for article (PubMed ID: 16600664)
1. Leucine-rich repeat kinase 2: relevance to Parkinson's disease.
Guo L; Wang W; Chen SG
Int J Biochem Cell Biol; 2006; 38(9):1469-75. PubMed ID: 16600664
[TBL] [Abstract][Full Text] [Related]
2. Conformational heterogeneity of the Roc domains in C. tepidum Roc-COR and implications for human LRRK2 Parkinson mutations.
Rudi K; Ho FY; Gilsbach BK; Pots H; Wittinghofer A; Kortholt A; Klare JP
Biosci Rep; 2015 Aug; 35(5):. PubMed ID: 26310572
[TBL] [Abstract][Full Text] [Related]
3. The Parkinson's disease-associated protein, leucine-rich repeat kinase 2 (LRRK2), is an authentic GTPase that stimulates kinase activity.
Guo L; Gandhi PN; Wang W; Petersen RB; Wilson-Delfosse AL; Chen SG
Exp Cell Res; 2007 Oct; 313(16):3658-70. PubMed ID: 17706965
[TBL] [Abstract][Full Text] [Related]
4. Leucine-rich repeat kinase 2 (LRRK2)/PARK8 possesses GTPase activity that is altered in familial Parkinson's disease R1441C/G mutants.
Li X; Tan YC; Poulose S; Olanow CW; Huang XY; Yue Z
J Neurochem; 2007 Oct; 103(1):238-47. PubMed ID: 17623048
[TBL] [Abstract][Full Text] [Related]
5. Understanding the GTPase Activity of LRRK2: Regulation, Function, and Neurotoxicity.
Nguyen AP; Moore DJ
Adv Neurobiol; 2017; 14():71-88. PubMed ID: 28353279
[TBL] [Abstract][Full Text] [Related]
6. The Parkinson disease gene LRRK2: evolutionary and structural insights.
Marín I
Mol Biol Evol; 2006 Dec; 23(12):2423-33. PubMed ID: 16966681
[TBL] [Abstract][Full Text] [Related]
7. Contribution of GTPase activity to LRRK2-associated Parkinson disease.
Tsika E; Moore DJ
Small GTPases; 2013; 4(3):164-70. PubMed ID: 24025585
[TBL] [Abstract][Full Text] [Related]
8. The GTPase function of LRRK2.
Taymans JM
Biochem Soc Trans; 2012 Oct; 40(5):1063-9. PubMed ID: 22988866
[TBL] [Abstract][Full Text] [Related]
9. The biology and pathobiology of LRRK2: implications for Parkinson's disease.
Moore DJ
Parkinsonism Relat Disord; 2008; 14 Suppl 2():S92-8. PubMed ID: 18602856
[TBL] [Abstract][Full Text] [Related]
10. Analysis of LRRK2 accessory repeat domains: prediction of repeat length, number and sites of Parkinson's disease mutations.
Mills RD; Mulhern TD; Cheng HC; Culvenor JG
Biochem Soc Trans; 2012 Oct; 40(5):1086-9. PubMed ID: 22988870
[TBL] [Abstract][Full Text] [Related]
11. Parkinson's disease-associated mutations in LRRK2 link enhanced GTP-binding and kinase activities to neuronal toxicity.
West AB; Moore DJ; Choi C; Andrabi SA; Li X; Dikeman D; Biskup S; Zhang Z; Lim KL; Dawson VL; Dawson TM
Hum Mol Genet; 2007 Jan; 16(2):223-32. PubMed ID: 17200152
[TBL] [Abstract][Full Text] [Related]
12. GTPase activity regulates kinase activity and cellular phenotypes of Parkinson's disease-associated LRRK2.
Biosa A; Trancikova A; Civiero L; Glauser L; Bubacco L; Greggio E; Moore DJ
Hum Mol Genet; 2013 Mar; 22(6):1140-56. PubMed ID: 23241358
[TBL] [Abstract][Full Text] [Related]
13. Revisiting the Roco G-protein cycle.
Terheyden S; Ho FY; Gilsbach BK; Wittinghofer A; Kortholt A
Biochem J; 2015 Jan; 465(1):139-47. PubMed ID: 25317655
[TBL] [Abstract][Full Text] [Related]
14. The Roco protein family: a functional perspective.
Marín I; van Egmond WN; van Haastert PJ
FASEB J; 2008 Sep; 22(9):3103-10. PubMed ID: 18523161
[TBL] [Abstract][Full Text] [Related]
15. Homo- and heterodimerization of ROCO kinases: LRRK2 kinase inhibition by the LRRK2 ROCO fragment.
Klein CL; Rovelli G; Springer W; Schall C; Gasser T; Kahle PJ
J Neurochem; 2009 Nov; 111(3):703-15. PubMed ID: 19712061
[TBL] [Abstract][Full Text] [Related]
16. The Roc-COR tandem domain of leucine-rich repeat kinase 2 forms dimers and exhibits conventional Ras-like GTPase properties.
Mills RD; Liang LY; Lio DS; Mok YF; Mulhern TD; Cao G; Griffin M; Kenche VB; Culvenor JG; Cheng HC
J Neurochem; 2018 Nov; 147(3):409-428. PubMed ID: 30091236
[TBL] [Abstract][Full Text] [Related]
17. The R1441C mutation of LRRK2 disrupts GTP hydrolysis.
Lewis PA; Greggio E; Beilina A; Jain S; Baker A; Cookson MR
Biochem Biophys Res Commun; 2007 Jun; 357(3):668-71. PubMed ID: 17442267
[TBL] [Abstract][Full Text] [Related]
18. Expression, purification and preliminary biochemical and structural characterization of the leucine rich repeat namesake domain of leucine rich repeat kinase 2.
Vancraenenbroeck R; Lobbestael E; Weeks SD; Strelkov SV; Baekelandt V; Taymans JM; De Maeyer M
Biochim Biophys Acta; 2012 Mar; 1824(3):450-60. PubMed ID: 22251894
[TBL] [Abstract][Full Text] [Related]
19. First model of dimeric LRRK2: the challenge of unrevealing the structure of a multidomain Parkinson's-associated protein.
Guaitoli G; Gilsbach BK; Raimondi F; Gloeckner CJ
Biochem Soc Trans; 2016 Dec; 44(6):1635-1641. PubMed ID: 27913672
[TBL] [Abstract][Full Text] [Related]
20. LRRK2 in Parkinson's disease: protein domains and functional insights.
Mata IF; Wedemeyer WJ; Farrer MJ; Taylor JP; Gallo KA
Trends Neurosci; 2006 May; 29(5):286-93. PubMed ID: 16616379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
